ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

ClinicalTrials.gov ID: NCT01174004

Public ClinicalTrials.gov record NCT01174004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease

Study identification

NCT ID
NCT01174004
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
199 participants

Conditions and interventions

Interventions

  • pimavanserin tartrate Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2010
Primary completion
Oct 31, 2012
Completion
Oct 31, 2012
Last update posted
Mar 25, 2014

2010 – 2012

United States locations

U.S. sites
62
U.S. states
26
U.S. cities
61
Facility City State ZIP Site status
Not listed Gilbert Arizona 85234
Not listed Phoenix Arizona 85004
Not listed Phoenix Arizona 85013
Not listed Tucson Arizona 85724
Not listed Carson California 90746
Not listed Fountain Valley California 92708
Not listed Fresno California 93720
Not listed Fullerton California 92835
Not listed Irvine California 92697
Not listed La Habra California 90631
Not listed La Jolla California 92037
Not listed Loma Linda California 92354
Not listed Oxnard California 93030
Not listed Pasadena California 91105
Not listed Reseda California 91335
Not listed Sunnyvale California 94085
Not listed Ventura California 93003
Not listed Danbury Connecticut 06810
Not listed Boca Raton Florida 33486
Not listed Bradenton Florida 34205
Not listed Naples Florida 34102
Not listed Orlando Florida 32806
Not listed Ormond Beach Florida 32174
Not listed Panama City Florida 32405
Not listed Port Charlotte Florida 33980
Not listed St. Petersburg Florida 33713
Not listed Augusta Georgia 30912
Not listed Decatur Georgia 30033
Not listed Elk Grove Village Illinois 60007
Not listed Glenview Illinois 60026
Not listed Kansas City Kansas 66160
Not listed Louisville Kentucky 40202
Not listed Scarborough Maine 04074
Not listed Baltimore Maryland 21287
Not listed Boston Massachusetts 02215
Not listed Novi Michigan 48377
Not listed Roseville Michigan 48066
Not listed Traverse City Michigan 49684
Not listed Flowood Mississippi 39232
Not listed St Louis Missouri 63110
Not listed Missoula Montana 59802
Not listed Toms River New Jersey 08755
Not listed Albany New York 12208
Not listed Commack New York 11725
Not listed Kingston New York 12401
Not listed New York New York 10016
Not listed Durham North Carolina 27705
Not listed Raleigh North Carolina 27607
Not listed Salisbury North Carolina 28144
Not listed Cincinnati Ohio 45219
Not listed Cleveland Ohio 44195
Not listed Columbus Ohio 43210
Not listed Toledo Ohio 43614
Not listed Greensburg Pennsylvania 15601
Not listed Providence Rhode Island 02906
Not listed Brentwood Tennessee 37027
Not listed Houston Texas 77030
Not listed Salt Lake City Utah 84108
Not listed Alexandria Virginia 22311
Not listed Roanoke Virginia 24018
Not listed Virginia Beach Virginia 23456
Not listed Milwaukee Wisconsin 53233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01174004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2014 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01174004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →